Monoclonal Antibodies for Oral Immunotherapy

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/481377

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Antibodies are the main line of defence the immune system utilises to target viruses and bacteria that invade our body. Raising the level of antibodies can therefore offer effective protection against disease. However, as antibodies cannot be taken orally (as a tablet) they have to be injected into the blood stream. We aim to overcome this limitation by generating antibodies that survive the passage through the stomach, allowing us to target conditions such as Crohn's disease.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2010

Funding Scheme: NHMRC Postgraduate Scholarships

Funding Amount: $69,684.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Clinical microbiology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Monoclonal Antibodies | Novel Biologics | Oral Immunotherapy

Related Links